AI CuratorAI-generated
Research summary · AI summary · not yet reviewedSubjects not reportedNot reportedPublished in a peer-reviewed journal
Mesenchymal Stem Cell Therapy for Multiple Sclerosis in Animal Models and Humans
A review published in 2026 summarizes potential therapeutic benefits of mesenchymal stem cell (MSC) therapy for MS, based on research in animal models and some observations in humans.
- Tags
- #MSResearch
- Most relevant to
- —
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
This review highlights MSCs as a promising area of research for MS treatment, exploring their immunological properties, which may provide new avenues for management strategies.
What this does not prove
The review does not present new clinical trial data or direct evidence of effectiveness; it only summarizes existing literature.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-30
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceMesenchymal Stem Cell Therapy for Multiple Sclerosis: Harnessing Immunological Properties. ↗DOI: 10.4062/biomolther.2026.141
Supporting passages (5)
publication datePublication date: 2026-10-30
interventionIn this context, cell transplantation therapy using mesenchymal stem cells (MSCs), hematopoietic stem cells, neural precursors, neural stem cells, and induced pluripotent stem cells is considered a feasible alternative therapeutic approach.
findingsThis review summarizes the potential therapeutic benefits of the latest MSC-based approaches for MS treatment in animal models and humans.
limitationsTitle: Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Harnessing Immunological Properties.
peer reviewedPublication types: Journal Article; Review
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.